Literature DB >> 23830626

Selenium in the redox regulation of the Nrf2 and the Wnt pathway.

Regina Brigelius-Flohé1, Anna Patricia Kipp.   

Abstract

Selenium deficiency is known to increase cancer risk by so far unclear mechanisms. Selenium exerts its biological effects via selenocysteine as an integral part of selenoproteins. Certain selenoproteins have redox properties, thereby providing a tool to regulate hydroperoxide-mediated signaling. Selenium deficiency does not only reduce synthesis of selenoproteins but also affects the expression of other proteins and even pathways. A moderate Se deficiency activates the Nrf2 and the Wnt pathways. The link between both pathways appears to be GSK3β which in the active state prepares Nrf2 as well as β-catenin, the key player in Wnt signaling, for ubiquitination and proteasomal degradation, thus silencing their transcriptional activity. Upon stimulation by Wnt signals, GSK3β becomes inactivated and transcription factors are stabilized. Many intermediate steps in both pathways can be modulated by hydroperoxides, making them predestined to be regulated by selenoproteins. Oxidation sensors are (i) Keap1 which keeps Nrf2 in the cytosol unless it is modified by hydroperoxides/electrophiles and (ii) nucleoredoxin (Nrx) which is associated with disheveled (Dvl). NOX1-derived H2O2 oxidizes Nrx leading to the liberation of Dvl and the activation of Wnt signaling. Selenium deficiency can support oxidation of both sensors and activate both pathways. The consequences are dual: while the Keap1/Nrf2 system is generally believed to protect against oxidative stress, diverse xenobiotics, inflammation, and carcinogenesis, the Wnt response is considered rather a risky one in these respects. However, not only healthy cells but also malignant ones benefit from intact Keap1/Nrf2 signaling, making a dysregulated hydroperoxide signaling a plausible explanation for the increased cancer risk in selenium deficiency.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GSK3ß; Keap1; Nrf2; Nucleoredoxin; Phase II enzymes; Selenium deficiency; Wnt

Mesh:

Substances:

Year:  2013        PMID: 23830626     DOI: 10.1016/B978-0-12-405882-8.00004-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  16 in total

Review 1.  Selenium at the redox interface of the genome, metabolome and exposome.

Authors:  Jolyn Fernandes; Xin Hu; M Ryan Smith; Young-Mi Go; Dean P Jones
Journal:  Free Radic Biol Med       Date:  2018-06-05       Impact factor: 7.376

Review 2.  Crosstalk between Nrf2 and Notch signaling.

Authors:  Nobunao Wakabayashi; Dionysios V Chartoumpekis; Thomas W Kensler
Journal:  Free Radic Biol Med       Date:  2015-05-21       Impact factor: 7.376

3.  Selenoprotein P influences colitis-induced tumorigenesis by mediating stemness and oxidative damage.

Authors:  Caitlyn W Barrett; Vishruth K Reddy; Sarah P Short; Amy K Motley; Mary K Lintel; Amber M Bradley; Tanner Freeman; Jefferson Vallance; Wei Ning; Bobak Parang; Shenika V Poindexter; Barbara Fingleton; Xi Chen; Mary K Washington; Keith T Wilson; Noah F Shroyer; Kristina E Hill; Raymond F Burk; Christopher S Williams
Journal:  J Clin Invest       Date:  2015-06-08       Impact factor: 14.808

4.  A conditional mouse expressing an activating mutation in NRF2 displays hyperplasia of the upper gastrointestinal tract and decreased white adipose tissue.

Authors:  Brittany M Bowman; Stephanie A Montgomery; Travis P Schrank; Jeremy M Simon; Travis S Ptacek; Tigist Y Tamir; Kathleen M Mulvaney; Seth J Weir; Tuong T Nguyen; Ryan M Murphy; Liza Makowski; D Neil Hayes; Xiaoxin L Chen; Scott H Randell; Bernard E Weissman; Michael B Major
Journal:  J Pathol       Date:  2020-08-29       Impact factor: 7.996

Review 5.  Redox Control of Skeletal Muscle Regeneration.

Authors:  Emmeran Le Moal; Vincent Pialoux; Gaëtan Juban; Carole Groussard; Hassane Zouhal; Bénédicte Chazaud; Rémi Mounier
Journal:  Antioxid Redox Signal       Date:  2017-02-06       Impact factor: 8.401

6.  Efficacy of auranofin as an inhibitor of desmoid progression.

Authors:  Kan Ito; Yoshihiro Nishida; Shunsuke Hamada; Koki Shimizu; Tomohisa Sakai; Bisei Ohkawara; Benjamin A Alman; Atsushi Enomoto; Kunihiro Ikuta; Hiroshi Koike; Jiarui Zhang; Kinji Ohno; Shiro Imagama
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

7.  Selenium-enriched polysaccharides from Pyracantha fortuneana (Se-PFPs) inhibit the growth and invasive potential of ovarian cancer cells through inhibiting β-catenin signaling.

Authors:  Qianling Sun; Mengmeng Dong; Zhihui Wang; Changdong Wang; Deqiao Sheng; Zhihong Li; Debin Huang; Chengfu Yuan
Journal:  Oncotarget       Date:  2016-05-10

8.  The effects of fenvalerate on hepatic and cerebral xenobiotic metabolizing enzymes in selenium and/or iodine deficient rats.

Authors:  Aydan Caglayan; Belma Kocer-Gumusel; Pinar Erkekoglu; Filiz Hincal
Journal:  Iran J Basic Med Sci       Date:  2016-10       Impact factor: 2.699

Review 9.  Interplay between cytosolic disulfide reductase systems and the Nrf2/Keap1 pathway.

Authors:  Edward E Schmidt
Journal:  Biochem Soc Trans       Date:  2015-08-03       Impact factor: 5.407

10.  Various Mechanisms Involve the Nuclear Factor (Erythroid-Derived 2)-Like (NRF2) to Achieve Cytoprotection in Long-Term Cisplatin-Treated Urothelial Carcinoma Cell Lines.

Authors:  Margaretha A Skowron; Günter Niegisch; Philipp Albrecht; Gommert van Koeveringe; Andrea Romano; Peter Albers; Wolfgang A Schulz; Michèle J Hoffmann
Journal:  Int J Mol Sci       Date:  2017-08-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.